EE752 What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024
Abstract
Authors
Hélène Moutier Salomé Rabarioelina Sandrine Bourguignon